CX3CR1 and myelodysplastic syndrome: Interestingly, studies on the expansion of MDSCs in the context of myelodysplastic syndrome (MDS), showed a high membrane expression of CX3CR1 and CXCR4 on patients MDSCs compared to healthy controls and that these levels were correlated with patients’ risk stratification [121].